Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Dietary carbohydrate modification alters serum metabolic profiles in individuals with the metabolic syndrome.

Lankinen M, Schwab U, Gopalacharyulu PV, Seppänen-Laakso T, Yetukuri L, Sysi-Aho M, Kallio P, Suortti T, Laaksonen DE, Gylling H, Poutanen K, Kolehmainen M, Oresic M.

Nutr Metab Cardiovasc Dis. 2010 May;20(4):249-57. doi: 10.1016/j.numecd.2009.04.009. Epub 2009 Jun 23.

PMID:
19553094
2.

Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study.

Kallio P, Kolehmainen M, Laaksonen DE, Kekäläinen J, Salopuro T, Sivenius K, Pulkkinen L, Mykkänen HM, Niskanen L, Uusitupa M, Poutanen KS.

Am J Clin Nutr. 2007 May;85(5):1417-27.

3.

A low-fat, high-complex carbohydrate diet supplemented with long-chain (n-3) fatty acids alters the postprandial lipoprotein profile in patients with metabolic syndrome.

Jiménez-Gómez Y, Marín C, Peérez-Martínez P, Hartwich J, Malczewska-Malec M, Golabek I, Kiec-Wilk B, Cruz-Teno C, Rodríguez F, Gómez P, Gómez-Luna MJ, Defoort C, Gibney MJ, Pérez-Jiménez F, Roche HM, López-Miranda J.

J Nutr. 2010 Sep;140(9):1595-601. doi: 10.3945/jn.109.120816. Epub 2010 Jul 14.

4.

Inflammation markers are modulated by responses to diets differing in postprandial insulin responses in individuals with the metabolic syndrome.

Kallio P, Kolehmainen M, Laaksonen DE, Pulkkinen L, Atalay M, Mykkänen H, Uusitupa M, Poutanen K, Niskanen L.

Am J Clin Nutr. 2008 May;87(5):1497-503.

5.

Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome.

Poppitt SD, Keogh GF, Prentice AM, Williams DE, Sonnemans HM, Valk EE, Robinson E, Wareham NJ.

Am J Clin Nutr. 2002 Jan;75(1):11-20.

6.

Very low carbohydrate diet significantly alters the serum metabolic profiles in obese subjects.

Gu Y, Zhao A, Huang F, Zhang Y, Liu J, Wang C, Jia W, Xie G, Jia W.

J Proteome Res. 2013 Dec 6;12(12):5801-11. doi: 10.1021/pr4008199. Epub 2013 Nov 18.

PMID:
24224694
7.
8.

Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome.

Laaksonen DE, Toppinen LK, Juntunen KS, Autio K, Liukkonen KH, Poutanen KS, Niskanen L, Mykkänen HM.

Am J Clin Nutr. 2005 Dec;82(6):1218-27.

9.

Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome.

Klemsdal TO, Holme I, Nerland H, Pedersen TR, Tonstad S.

Nutr Metab Cardiovasc Dis. 2010 Mar;20(3):195-201. doi: 10.1016/j.numecd.2009.03.010. Epub 2009 Jun 6.

PMID:
19502017
10.

Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham Offspring Cohort.

McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PW, Jacques PF.

Diabetes Care. 2004 Feb;27(2):538-46.

PMID:
14747241
11.

The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.

Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

Am J Clin Nutr. 2008 Jan;87(1):114-25.

12.

Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome.

Volek JS, Fernandez ML, Feinman RD, Phinney SD.

Prog Lipid Res. 2008 Sep;47(5):307-18. doi: 10.1016/j.plipres.2008.02.003. Epub 2008 Mar 15. Review.

PMID:
18396172
13.

Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome.

Feinman RD, Volek JS.

Scand Cardiovasc J. 2008 Aug;42(4):256-63. doi: 10.1080/14017430802014838. Review.

PMID:
18609058
14.

Carbohydrate-restricted versus low-glycemic-index diets for the treatment of insulin resistance and metabolic syndrome.

Wood RJ, Fernandez ML.

Nutr Rev. 2009 Mar;67(3):179-83. doi: 10.1111/j.1753-4887.2009.00186.x. Review.

PMID:
19239633
15.
16.

A reduced carbohydrate, increased protein diet stabilizes glycemic control and minimizes adipose tissue glucose disposal in rats.

Baum JI, Layman DK, Freund GG, Rahn KA, Nakamura MT, Yudell BE.

J Nutr. 2006 Jul;136(7):1855-61.

17.

Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome.

Tremblay AJ, Després JP, Piché ME, Nadeau A, Bergeron J, Alméras N, Tremblay A, Lemieux S.

Metabolism. 2004 Mar;53(3):310-7.

PMID:
15015142
18.

A science-based, clinically tested dietary approach for the metabolic syndrome.

Schiltz B, Minich DM, Lerman RH, Lamb JJ, Tripp ML, Bland JS.

Metab Syndr Relat Disord. 2009 Jun;7(3):187-92. doi: 10.1089/met.2008.0051.

PMID:
19450142
19.

The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial.

Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J, Williams M, Gracely EJ, Samaha FF.

Ann Intern Med. 2004 May 18;140(10):778-85.

PMID:
15148064
20.

No difference in body weight decrease between a low-glycemic-index and a high-glycemic-index diet but reduced LDL cholesterol after 10-wk ad libitum intake of the low-glycemic-index diet.

Sloth B, Krog-Mikkelsen I, Flint A, Tetens I, Björck I, Vinoy S, Elmståhl H, Astrup A, Lang V, Raben A.

Am J Clin Nutr. 2004 Aug;80(2):337-47.

Supplemental Content

Support Center